Post-translational modification of plant-made foreign proteins; glycosylation and beyond

Biotechnology Advances

Volumn 30, Issue 2, 2012, Pages 410-418

  Webster, Diane E ^a   Thomas, Merlin C ^b  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Glycosylation; Lipidation; Plant made proteins; Post translational modification; Proline hydroxylation; Recombinant proteins

Indexed keywords

DEGREE OF TOLERANCE; DYNAMIC INTERACTION; EXPRESSION SYSTEM; HIGH QUALITY; LIPIDATION; LOCALISATION; NATIVE PROTEINS; POST-TRANSLATIONAL MODIFICATION; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN ACTIVITY; PROTEIN ENGINEERING; PROTEIN PROCESSING; RATIONAL DESIGN; RECOMBINANT PROTEIN;

AMINO ACIDS; ESTERIFICATION; GENETIC ENGINEERING; GLYCOSYLATION; HYDROXYLATION; PRODUCT DESIGN;

RECOMBINANT PROTEINS;

RECOMBINANT PROTEIN; VEGETABLE PROTEIN;

COST-BENEFIT ANALYSIS; DRUG; GENE EXPRESSION; GENOME; MOLECULAR ANALYSIS; PROTEIN; RECOMBINATION;

BIOSYNTHESIS; GENETICS; GLYCOSYLATION; METABOLISM; METHODOLOGY; PROTEIN ENGINEERING; PROTEIN PROCESSING; REVIEW; TRANSGENIC PLANT;

GLYCOSYLATION; PLANT PROTEINS; PLANTS, GENETICALLY MODIFIED; PROTEIN ENGINEERING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS;

EUKARYOTA;

EID: 84856958234     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2011.07.015     Document Type: Review

References (111)

1. Adolf G.R., Kalsner I., Ahorn H., Maurer-Fogy I., Cantell K. Natural human interferon-alpha 2 is O-glycosylated. Biochem J 1991, 276:511-518.
2. Altmann F. The role of protein glycosylation in allergy. Int Arch Allergy Immunol 2007, 142:99-115.
3. Apweiler R., Hermjakob H., Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1999, 1473:4-8.
4. Bakker H., Bardor M., Molthoff J.W., Gomord V., Elbers I., Stevens L.H., et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci U S A 2001, 98:2899-2904.
5. Bakker H., Rouwendal G.J., Karnoup A.S., Florack D.E., Stoopen G.M., Helsper J.P., et al. An antibody produced in tobacco expressing a hybrid beta-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes. Proc Natl Acad Sci U S A 2006, 103:7577-7582.
6. Boevink P., Oparka K., Santa Cruz S., Martin B., Betteridge A., Hawes C. Stacks on tracks: the plant Golgi apparatus traffics on an actin/ER network. Plant J 1998, 15:441-447.
7. Bosch D., Schots A. Plant glycans: friend or foe in vaccine development?. Expert Rev Vaccines 2010, 9:835-842.
8. Butler M. Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by mammalian cell systems. Cytotechnology 2006, 50:57-76.
9. Buttner-Mainik A., Parsons J., Jerome H., Hartmann A., Lamer S., Schaaf A., et al. Production of biologically active recombinant human factor H in Physcomitrella. Plant Biotechnol J 2011, 9:373-383.
10. Castilho A., Pabst M., Leonard R., Veit C., Altmann F., Mach L., et al. Construction of a functional CMP-sialic acid biosynthesis pathway in Arabidopsis. Plant Physiol 2008, 147:331-339.
11. Castilho A., Strasser R., Stadlmann J., Grass J., Jez J., Gattinger P., et al. In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 2010, 285:15923-15930.
12. Castilho A., Gattinger P., Grass J., Jez J., Pabst M., Altmann F., et al. N-Glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans. Glycobiology 2011, 21:813-823.
13. Castro P.M., Ison A.P., Hayter P.M., Bull A.T. The macroheterogeneity of recombinant human interferon-gamma produced by Chinese-hamster ovary cells is affected by the protein and lipid content of the culture medium. Biotechnol Appl Biochem 1995, 21:87-100.
14. Chung C.H., Mirakhur B., Chan E., Le Q.T., Berlin J., Morse M., et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 2008, 358:1109-1117.
15. Commins S.P., Platts-Mills T.A. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol 2009, 124:652-657.
16. Daskalova S.M., Pah A.R., Baluch D.P., Lopez L.C. The Arabidopsis thaliana putative sialyltransferase resides in the Golgi apparatus but lacks the ability to transfer sialic acid. Plant Biol 2009, 11:284-299.
17. Daskalova S.M., Radder J.E., Cichacz Z.A., Olsen S.H., Tsaprailis G., Mason H., et al. Engineering of N. benthamiana plants for production of N-acetylgalactosamine-glycosylated proteins-towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation. BMC Biotechnol 2010, 10:62.
18. Davies H.M. Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 2010, 8:845-861.
19. Decker E.L., Reski R. Moss bioreactors producing improved biopharmaceuticals. Curr Opin Biotechnol 2007, 18:393-398.
20. Egrie J.C., Browne J.K. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001, 84(Suppl. 1):3-10.
21. Eskelin K., Ritala A., Suntio T., Blumer S., Holkeri H., Wahlstrom E.H., et al. Production of a recombinant full-length collagen type I alpha-1 and of a 45-kda collagen type I alpha-1 fragment in barley seeds. Plant Biotechnol J 2009, 7:657-672.
22. Floss D.M., Sack M., Arcalis E., Stadlmann J., Quendler H., Rademacher T., et al. Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnol J 2009, 7:899-913.
23. Fujiyama K., Furukawa A., Katsura A., Misaki R., Omasa T., Seki T. Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1,4)-galactosyltransferase. Biochem Biophys Res Commun 2007, 358:85-91.
24. Gill D.J., Chia J., Senewiratne J., Bard F. Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes. J Cell Biol 2010, 189:843-858.
25. Gill D.J., Clausen H., Bard F. Location, location, location: new insights into O-GalNAc protein glycosylation. Trends Cell Biol 2011, 21:149-158.
26. Glenz K., Bouchon B., Stehle T., Wallich R., Simon M.M., Warzecha H. Production of a recombinant bacterial lipoprotein in higher plant chloroplasts. Nat Biotechnol 2006, 24:76-77.
27. Goetze A.M., Liu Y.D., Zhang Z., Shah B., Lee E., Bondarenko P.V., et al. High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Glycobiol 2011, 21:949-959.
28. Gomord V., Faye L. Posttranslational modification of therapeutic proteins in plants. Curr Opin Plant Biol 2004, 7:171-181.
29. Gomord V., Fitchette A.C., Menu-Bouaouiche L., Saint-Jore-Dupas C., Plasson C., Michaud D., et al. Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J 2010, 8:564-587.
30. Gordon M.K., Hahn R.A. Collagens. Cell Tissue Res 2010, 339:247-257.
31. Gorr G., Jost W. Glycosylation design in transgenic moss for better product efficacy. Bioprocess J 2005, 4:26-30.
32. Gorres K.L., Raines R.T. Prolyl 4-hydroxylase. Crit Rev Biochem Mol Biol 2010, 45:106-124.
33. Harris J.M., Chess R.B. Effect of PEGylation on pharmaceuticals. Nat Rev Drug Discov 2003, 2:214-221.
34. Hemsley P.A., Grierson C.S. Multiple roles for protein palmitoylation in plants. Trends Plant Sci 2008, 13:295-302.
35. Hennig A., Bonfig K., Roitsch T., Warzecha H. Expression of the recombinant bacterial outer surface protein A in tobacco chloroplasts leads to thylakoid localisation and loss of photosynthesis. FEBS J 2007, 274:5749-5758.
36. Hennig A., Reinders Y., Giritch A., Reinders J., Warzecha H. Assessment of different expression strategies for the production of a recombinant lipoprotein vaccine in plants. Open Biotechnol J 2008, 2:51-55.
37. Higgins E. Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj J 2010, 27:211-225.
38. Hu A., Cattaneo R., Schwartz S., Norrby E. Role of N-linked oligosaccharide chains in the processing and antigenicity of measles virus haemagglutinin protein. J Gen Virol 1994, 75:1043-1052.
39. Jacobs P.P., Callewaert N. N-glycosylation engineering of biopharmaceutical expression systems. Curr Mol Med 2009, 9:774-800.
40. Jin C., Altmann F., Strasser R., Mach L., Schahs M., Kunert R., et al. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. Glycobiology 2008, 18:235-241.
41. Johnston M.J., Frahm G., Li X., Durocher Y., Hefford M.A. O-linked glycosylation leads to decreased thermal stability of interferon alpha 2b as measured by two orthogonal techniques. Pharm Res 2011, 28:1661-1667.
42. Karnoup A.S., Turkelson V., Anderson W.H. O-linked glycosylation in maize-expressed human iga1. Glycobiology 2005, 15:965-981.
43. Kieliszewski M.J., Shpak E. Synthetic genes for the elucidation of glycosylation codes for arabinogalactan-proteins and other hydroxyproline-rich glycoproteins. Cell Mol Life Sci 2001, 58:1386-1398.
44. Kieliszewski MJ, Xu J. Methods of producing peptides/proteins and peptides/proteins produced thereby. United State Patent, Publication No. US-20060026719, 2006.
45. Kilcoyne M., Shah M., Gerlach J.Q., Bhavanandan V., Nagaraj V., Smith A.D., et al. O-glycosylation of protein subpopulations in alcohol-extracted rice proteins. J Plant Physiol 2009, 166:219-232.
46. Kishimoto T., Watanabe M., Mitsui T., Hori H. Glutelin basic subunits have a mammalian mucin-type O-linked disaccharide side chain. Arch Biochem Biophys 1999, 370:271-277.
47. Ko K., Tekoah Y., Rudd P.M., Harvey D.J., Dwek R.A., Spitsin S., et al. Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A 2003, 100:8013-8018.
48. Koprivova A., Stemmer C., Altmann F., Hoffmann A., Kopriva S., Gorr G., et al. Targeted knockouts of Physcomitrella lacking plant-specific immunogenic N-glycans. Plant Biotechnol J 2004, 2:517-523.
49. Krane S.M. The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids 2008, 35:703-710.
50. Lanteri M., Giordanengo V., Vidal F., Gaudray P., Lefebvre J.C. A complete alpha1,3-galactosyltransferase gene is present in the human genome and partially transcribed. Glycobiology 2002, 12:785-792.
51. Lauc G., Essafi A., Huffman J.E., Hayward C., Knezevic A., Kattla J.J., et al. Genomics meets glycomics-the first GWAS study of human N-glycome identifies hNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet 2011, 6:e1001256.
52. Li H., d'Anjou M. Pharmacological significance of glycosylation in therapeutic proteins. Curr Opin Biotechnol 2009, 20:678-684.
53. Ling H.Y., Pelosi A., Walmsley A.M. Current status of plant-made vaccines for veterinary purposes. Expert Rev Vaccines 2010, 9:971-982.
54. Loignon M., Perret S., Kelly J., Boulais D., Cass B., Bisson L., et al. Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells. BMC Biotechnol 2008, 8:65.
55. Marusic C., Nuttall J., Buriani G., Lico C., Lombardi R., Baschieri S., et al. Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells. BMC Biotechnol 2007, 7:12.
56. McCartney L., Marcus S.E., Knox J.P. Monoclonal antibodies to plant cell wall xylans and arabinoxylans. J Histochem Cytochem 2005, 53:543-546.
57. Meinnel T., Giglione C. Protein lipidation meets proteomics. Front Biosci 2008, 13:6326-6340.
58. Merle C., Perret S., Lacour T., Jonval V., Hudaverdian S., Garrone R., et al. Hydroxylated human homotrimeric collagen I in Agrobacterium tumefaciens-mediated transient expression and in transgenic tobacco plant. FEBS Lett 2002, 515:114-118.
59. Misaki R., Fujiyama K., Seki T. Expression of human CMP-N-acetylneuraminic acid synthetase and CMP-sialic acid transporter in tobacco suspension-cultured cell. Biochem Biophys Res Commun 2006, 339:1184-1189.
60. Myllyharju J. Recombinant collagen trimers from insect cells and yeast. Methods Mol Biol 2009, 522:51-62.
61. Nagels B., Van Damme E.J., Pabst M., Callewaert N., Weterings K. Production of complex multiantennary N-glycans in Nicotiana benthamiana plants. Plant Physiol 2011, 155:1103-1112.
62. Novak J., Tomana M., Kilian M., Coward L., Kulhavy R., Barnes S., et al. Heterogeneity of O-glycosylation in the hinge region of human IgA1. Mol Immunol 2000, 37:1047-1056.
63. Oda Y., Hosokawa N., Wada I., Nagata K. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 2003, 299:1394-1397.
64. Palacpac N.Q., Yoshida S., Sakai H., Kimura Y., Fujiyama K., Yoshida T., et al. Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc Natl Acad Sci U S A 1999, 96:4692-4697.
65. Plotkin S.A. Correcting a public health fiasco: the need for a new vaccine against Lyme disease. Clin Infect Dis 2011, 52(Suppl. 3):s271-s275.
66. Purcell A.W., van Driel I.R., Gleeson P.A. Impact of glycans on T-cell tolerance to glycosylated self-antigens. Immunol Cell Biol 2008, 86:574-579.
67. Raju T.S. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol 2008, 20:471-478.
68. Ramshaw J.A., Shah N.K., Brodsky B. Gly-X-Y tripeptide frequencies in collagen: a context for host-guest triple-helical peptides. J Struct Biol 1998, 122:86-91.
69. Rayon C., Lerouge P., Faye L. The protein N-glycosylation in plants. J Exp Biol 1998, 49:1463-1472.
70. Ritala A., Wahlstrom E.H., Holkeri H., Hafren A., Makelainen K., Baez J., et al. Production of a recombinant industrial protein using barley cell cultures. Protein Expr Purif 2008, 59:274-281.
71. Rouwendal G.J., Wuhrer M., Florack D.E., Koeleman C.A., Deelder A.M., Bakker H., et al. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III. Glycobiology 2007, 17:334-344.
72. Saint-Jore-Dupas C., Faye L., Gomord V. From planta to pharma with glycosylation in the toolbox. Trends Biotechnol 2007, 25:317-323.
73. Salaun C., Greaves J., Chamberlain L.H. The intracellular dynamic of protein palmitoylation. J Cell Biol 2010, 191:1229-1238.
74. Schahs M., Strasser R., Stadlmann J., Kunert R., Rademacher T., Steinkellner H. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnol J 2007, 5:657-663.
75. Seifert G.J., Roberts K. The biology of arabinogalactan proteins. Annu Rev Plant Biol 2007, 58:137-161.
76. Shpak E., Leykam J.F., Kieliszewski M.J. Synthetic genes for glycoprotein design and the elucidation of hydroxyproline-O-glycosylation codes. Proc Natl Acad Sci U S A 1999, 96:14736-14741.
77. Shpak E., Barbar E., Leykam J.F., Kieliszewski M.J. Contiguous hydroxyproline residues direct hydroxyproline arabinosylation in Nicotiana tabacum. J Biol Chem 2001, 276:11272-11278.
78. Sinclair A.M., Elliott S. Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J Pharm Sci 2005, 94:1626-1635.
79. Singh S.K., Stephani J., Schaefer M., Kalay H., Garcia-Vallejo J.J., den Haan J., et al. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation. Mol Immunol 2009, 47:164-174.
80. Smotrys J.E., Linder M.E. Palmitoylation of intracellular signalling proteins: regulation and function. Annu Rev Biochem 2004, 73:559-587.
81. Sourrouille C., Marquet-Blouin E., D'Aoust M.A., Kiefer-Meyer M.C., Seveno M., Pagny-Salehabadi S., et al. Down-regulated expression of plant-specific glycoepitopes in alfalfa. Plant Biotechnol J 2008, 6:702-721.
82. Srikrishna G., Huttunen H.J., Johansson L., Weigle B., Yamaguchi Y., Rauvala H., et al. N-glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J Neurochem 2002, 80:998-1008.
83. Stein H., Wilensky M., Tsafrir Y., Rosenthal M., Amir R., Avraham T., et al. Production of bioactive, post-translationally modified, heterotrimeric, human recombinant type-I collagen in transgenic tobacco. Biomacromolecules 2009, 10:2640-2645.
84. Strasser R., Altmann F., Mach L., Glossl J., Steinkellner H. Generation of Arabidopsis thaliana plants with complex N-glycans lacking beta1,2-linked xylose and core alpha1,3-linked fucose. FEBS Lett 2004, 561:132-136.
85. Strasser R., Stadlmann J., Schahs M., Stiegler G., Quendler H., Mach L., et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnol J 2008, 6:392-402.
86. Strasser R., Castilho A., Stadlmann J., Kunert R., Quendler H., Gattinger P., et al. Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile. J Biol Chem 2009, 284:20479-20485.
87. Streatfield S.J. Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 2007, 5:2-15.
88. Stulemeijer I.J., Joosten M.H. Post-translational modification of host proteins in pathogen-triggered defence signalling in plants. Mol Plant Pathol 2008, 9:545-560.
89. Tabak L.A. The role of mucin-type o-glycans in eukaryotic development. Semin Cell Dev Biol 2010, 21:616-621.
90. Tian E., Ten Hagen K.G. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj J 2009, 26:325-334.
91. Umana P., Jean-Mairet J., Moudry R., Amstutz H., Bailey J.E. Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nat Biotechnol 1999, 17:176-180.
92. Vietor R., Loutelier-Bourhis C., Fitchette A.-C., Margerie P., Gonneau M., Faye L., et al. Protein N-glycosylation is similar in the moss Physcomitrella patens and in higher plants. Planta 2003, 218:269-275.
93. Vitale A., Pedrazzini E. Recombinant pharmaceuticals from plants: the plant endomembrane system as bioreactor. Mol Interv 2005, 5:216-225.
94. Walsh G. Post-translational modifications of protein biopharmaceuticals. Drug Discov Today 2010, 15:773-780.
95. Wee E.G., Sherrier D.J., Prime T.A., Dupree P. Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell 1998, 10:1759-1768.
96. Weis J.J., Ma Y., Erdile L.F. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect Immun 1994, 62:4632-4636.
97. Weise A., Altmann F., Rodriguez-Franco M., Sjoberg E.R., Bäumer W., Launhardt H., et al. High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella δ-fuc-t δ-xyl-t mutant. Plant Biotech J 2007, 5:389-401.
98. Werle M., Bernkop-Schnurch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 2006, 30:351-367.
99. Whaley K.J., Hiatt A., Zeitlin L. Emerging antibody products and Nicotiana manufacturing. Hum Vaccin 2011, 7.
100. Willats W.G., Marcus S.E., Knox J.P. Generation of monoclonal antibody specific to (1→5)-alpha-l-arabinan. Carbohydr Res 1998, 308:149-152.
101. Wilson I.B.H. Glycosylation of proteins in plants and invertebrates. Curr Opin Struct Biol 2002, 12:569-577.
102. Xu J., Tan L., Goodrum K.J., Kieliszewski M.J. High-yields and extended serum half-life of human interferon alpha2b expressed in tobacco cells as arabinogalactan-protein fusions. Biotechnol Bioeng 2007, 97:997-1008.
103. Xu J., Tan L., Lamport D.T., Showalter A.M., Kieliszewski M.J. The O-hyp glycosylation code in tobacco and Arabidopsis and a proposed role of Hyp-glycans in secretion. Phytochemistry 2008, 69:1631-1640.
104. Xu J., Okada S., Tan L., Goodrum K.J., Kopchick J.J., Kieliszewski M.J. Human growth hormone expressed in tobacco cells as an arabinogalactan-protein fusion glycoprotein has a prolonged serum life. Transgenic Res 2010, 19:849-867.
105. Xu J., Ge X., Dolan M.C. Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnol Adv 2011, 29:278-299.
106. Ytterberg A.J., Jensen O.N. Modification-specific proteomics in plant biology. J Proteomics 2010, 73:2249-2266.
107. Zeleny R., Kolarich D., Strasser R., Altmann F. Sialic acid concentrations in plants are in the range of inadvertent contamination. Planta 2006, 224:222-227.
108. Zhang C., Baez J., Glatz C.E. Purification and characterization of a 44-kda recombinant collagen I alpha 1 fragment from corn grain. J Agric Food Chem 2009, 57:880-887.
109. Zhang C., Baez J., Pappu K.M., Glatz C.E. Purification and characterization of a transgenic corn grain-derived recombinant collagen type I alpha 1. Biotechnol Prog 2009, 25:1660-1668.
110. Zhou F., Badillo-Corona J.A., Karcher D., Gonzalez-Rabade N., Piepenburg K., Borchers A.M., et al. High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes. Plant Biotechnol J 2008, 6:897-913.
111. Zuniga L., Calvo B. Regulatory aspects of biosimilars in Europe. Trends Biotechnol 2009, 27:385-387.